"This stock is getting some appeal"Fabulous, and where might that be.Honestly we have heard every bit of cr@p before. P.S, for years by the way.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%